Protein kinase C epsilon affects mitochondrial function through estrogen-related receptor alpha

Cellular Signalling

Volumn 23, Issue 9, 2011, Pages 1473-1478

  Lu, Na ^a   Wang, Wenxian ^a,c   Liu, Jinsong ^a   Wong, Chi Wai ^b  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b NeuMed Pharmaceuticals Limited   (Hong Kong)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ERR ; Mitochondria; PKC

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; ESTROGEN RELATED RECEPTOR ALPHA; HORMONE RECEPTOR STIMULATING AGENT; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHORBOL ESTER; PROTEIN KINASE C EPSILON; PYRUVATE DEHYDROGENASE KINASE 4; REACTIVE OXYGEN METABOLITE; SERINE; THREONINE; UNCLASSIFIED DRUG; XCT 790;

ARTICLE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RESIDUE ANALYSIS;

ACYL-COA DEHYDROGENASE; ANALYSIS OF VARIANCE; APOPTOSIS; CARBAZOLES; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CLONING, MOLECULAR; HOMEOSTASIS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NITRILES; PPAR ALPHA; PROTEIN KINASE C-EPSILON; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SUCCINATE DEHYDROGENASE; THIAZOLES; TRANSFECTION;

EID: 79958852642     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.04.010     Document Type: Article

References (41)

1. Reyland M.E. Front. Biosci. 2009, 14:2386-2399.
2. Konopatskaya O., Poole A.W. Trends Pharmacol. Sci. 2010, 31(1):8-14.
3. Gorin M.A., Pan Q. Mol. Cancer 2009, 8:9.
4. Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Science. 1998, 281(5385):2042-2045.
5. Fields A.P., Regala R.P. Pharmacol. Res. 2007, 55(6):487-497.
6. Goekjian P.G., Jirousek M.R. Expert Opin. Investig. Drugs 2001, 10(12):2117-2140.
7. Echave P., Machado-da-Silva G., Arkell R.S., Duchen M.R., Jacobson J., Mitter R., Lloyd A.C. J. Cell Sci. 2009, 122(Pt 24):4516-4525.
8. Giguere V. Endocr. Rev. 2008, 29(6):677-696.
9. Handschin C., Spiegelman B.M. Endocr. Rev. 2006, 27(7):728-735.
10. Wang J., Fang F., Huang Z., Wang Y., Wong C. FEBS Lett. 2009, 583(4):643-647.
11. Huang Z., Fang F., Wang J., Wong C.W. FEBS Lett. 2010, 584(1):22-26.
12. Xu J., Liao X., Wong C. Int. J. Cancer 2010, 126(4):1029-1035.
13. Wang J., Wang Y., Wong C. Cell Prolif. 2010, 43(2):103-113.
14. Chen L., Wong C. Biol. Pharm. Bull. 2009, 32(7):1199-1203.
15. Nie Y., Wong C. J. Cell. Mol. Med. 2009, 13(9B):3051-3060.
16. Liao X., Wang Y., Wong C.-W. Br. J. Pharmacol. 2010, 9999(999A).
17. Wang W., Wong C.W. J. Mol. Med. 2010, 88(3):309-317.
18. Wu F., Wang J., Wang Y., Kwok T.-T., Kong S.-K., Wong C. Chem. Biol. Interact. 2009, 181(2):236-242.
19. Wang Y., Fang F., Wong C.W. Biochem. Pharmacol. 2010, 80(1):80-85.
20. Huss J.M., Torra I.P., Staels B., Giguere V., Kelly D.P. Mol. Cell. Biol. 2004, 24(20):9079-9091.
21. Sladek R., Bader J., Giguere V. Mol. Cell. Biol. 1997, 17(9):5400-5409.
22. Wende A.R., Huss J.M., Schaeffer P.J., Giguere V., Kelly D.P. Mol. Cell. Biol. 2005, 25(24):10684-10694.
23. Busch B.B., Stevens W.C., Martin R., Ordentlich P., Zhou S., Sapp D.W., Horlick R.A., Mohan R. J. Med. Chem. 2004, 47(23):5593-5596.
24. Coward P., Lee D., Hull M.V., Lehmann J.M. PNAS. 2001, 98(15):8880-8884.
25. Stein R.A., McDonnell D.P. Endocr. Relat. Cancer 2006, 13(Suppl 1):S25-S32.
26. Xu T.R., He G., Rumsby M.G. J. Cell. Biochem. 2009, 106(4):633-642.
27. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., Giguere V. Cell Metab. 2007, 5(5):345-356.
28. Stein R.A., Chang C.-y., Kazmin D.A., Way J., Schroeder T., Wergin M., Dewhirst M.W., McDonnell D.P. Cancer Res. 2008, 68(21):8805-8812.
29. Aziz M.H., Manoharan H.T., Church D.R., Dreckschmidt N.E., Zhong W., Oberley T.D., Wilding G., Verma A.K. Cancer Res. 2007, 67(18):8828-8838.
30. Aziz M.H., Manoharan H.T., Sand J.M., Verma A.K. Mol. Carcinog. 2007, 46(8):646-653.
31. Perletti G.P., Concari P., Brusaferri S., Marras E., Piccinini F., Tashjian A.H. Oncogene 1998, 16(25):3345-3348.
32. Ueffing M., Lovric J., Philipp A., Mischak H., Kolch W. Oncogene 1997, 15(24):2921-2927.
33. Cai H., Smola U., Wixler V., Eisenmann-Tappe I., Diaz-Meco M.T., Moscat J., Rapp U., Cooper G.M. Mol. Cell. Biol. 1997, 17(2):732-741.
34. Cacace A.M., Ueffing M., Philipp A., Han E.K., Kolch W., Weinstein I.B. Oncogene 1996, 13(12):2517-2526.
35. Soh J.W., Weinstein I.B. J. Biol. Chem. 2003, 278(36):34709-34716.
36. Kampfer S., Windegger M., Hochholdinger F., Schwaiger W., Pestell R.G., Baier G., Grunicke H.H., Uberall F. J. Biol. Chem. 2001, 276(46):42834-42842.
37. Okhrimenko H., Lu W., Xiang C., Hamburger N., Kazimirsky G., Brodie C. Cancer Res. 2005, 65(16):7301-7309.
38. Wu D., Thakore C.U., Wescott G.G., McCubrey J.A., Terrian D.M. Oncogene 2004, 23(53):8659-8672.
39. Ding L., Wang H., Lang W., Xiao L. J. Biol. Chem. 2002, 277(38):35305-35313.
40. Baffy G. Mitochondrion 2010, 10(3):243-252.
41. Derdak Z., Mark N.M., Beldi G., Robson S.C., Wands J.R., Baffy G. Cancer Res. 2008, 68(8):2813-2819.